Zovirax site receives FDA Warning Letter

Share this article:
The Zovirax (acyclovir) ointment Web site, along with a consumer STD awareness deck card, misleadingly suggest to consumers that the GlaxoSmithKline product may prevent transmission of genital herpes infections, according to an FDA Warning Letter. The agency says that neither substantial evidence nor clinical experience have demonstrated this claim.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions